News
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The Cannabis and Psychedelics sectors received a mix of signals over the last fortnight: from regulatory delays and scientific breakthroughs to market consolidation and a wave of Q1 2026 earnings – all adding up to an industry that is finding its commercial footing even as political clarity remains elusive. Below we've outlined ...
Decibel Reports Q1 2026 Financial Results
CALGARY – Decibel Cannabis Company Inc. posted its financial results for the first quarter of 2026, showing notable gains in both domestic and international operations. The producer highlighted continued momentum from its branded products in Canada and a sharp rise in export activity. The company reported net revenue of $29.8 million for the three months ...
TSA Lists Medical Cannabis as Permitted, The Rules Page Is Still Blank
SPRINGFIELD – Travelers navigating state-legal Cannabis programs now have clearer federal agency direction on what to expect at airport security. The Transportation Security Administration (TSA) revised its public “What Can I Bring?” tool to list medical Cannabis as permitted in both carry-on and checked bags. The instructions, however, have not yet been clearly defined. The ...
Rob Van Dam Enters Cannabis Wellness with New Hemp-Derived E-Commerce Platform
LOS ANGELES – WWE Hall of Famer Rob Van Dam aka RVD, long known for his open support of Cannabis, has stepped into the wellness side of the industry with a fresh venture. The move combines his personal experience with products aimed at recovery and everyday use, reflecting how athletes and fans increasingly turn to ...
Leafwell Brings Medical Cannabis to the Benefits Table
CHICAGO – When Emily Fisher, the CEO and founder of virtual Cannabis-based care clinic Leafwell, was navigating her first breast cancer diagnosis, she turned to Cannabis out of desperation, not conviction. There was no physician guidance, no dosing protocol, no formal framework – just a tincture, and unexpected relief. That gap in clinical structure became ...
Cannabis 3.0: Why the Next Phase of the Industry Will Be Built on Platforms, Not Products
NEW YORK- The Cannabis industry is entering a new phase of development. The first phase of the legal Cannabis market was defined by access. Cannabis 1.0 was about legalization, licensing, compliance, and the basic right of consumers and patients to purchase regulated products. The central question was whether legal Cannabis could exist at all. Operators, ...
What’s in a Jar? For Cannabis Concentrate Brands, Quite a Lot
LOS ANGELES – The packaging debate in Cannabis manufacturing rarely makes headlines. But the choice between glass and plastic for concentrate products is one that shapes what a brand becomes and what it can prove. The global Cannabis concentrate market, valued at roughly $1.6 billion in 2025, is projected to reach $9 billion by 2036 ...
UK Medical Cannabis H1 2025: The Market Still Running on Trust
LONDON – You won't find the echoes of this revolution in the National Health Service (NHS) waiting lists or General Practitioner (GP) surgeries. It lives instead in a constellation of private clinics spread across the country, in carefully labelled jars of flower, in the inboxes of tens of thousands of patients who, until recently, had ...
Virginia Cannabis Licenses Delayed Again After Spanberger Veto
RICHMOND-Virginia’s long-delayed adult-use Cannabis market has suffered another major setback after Governor Abigail Spanberger vetoed legislation that would have created a regulated retail sales framework for the Commonwealth. The veto means Virginia will remain in the unusual position of allowing adult possession and home cultivation while continuing to block a legal adult-use retail market. For ...
Planet 13 Secures Florida Approval for BHO Extraction Lab
LAS VEGAS – Planet 13 Holdings Inc. announced that it has received approval from the Florida Office of Medical Marijuana Use (OMMU) for its butane hash oil (BHO) extraction facility in the state. The approval completes the final major infrastructure investment in Planet 13 Florida's operational buildout and, for the first time, enables the company ...
FDA Grants Breakthrough Designation to Vertanical Cannabis-Based Pain Drug
BERLIN – The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to VER-01, a Cannabis-derived, non-opioid investigational drug developed by Germany's VERTANICAL for the treatment of chronic low back pain. VER-01 is a standardized, pharmaceutical-grade full-spectrum extract from a specific Cannabis sativa strain (DKJ127). It contains primarily THC along with cannabigerol (CBG) ...
Apollo Acquires Emerald in $1.5B Deal: What’s Next for MJBizCon?
LOS ANGELES – Apollo Global Management Inc., one of the world's most powerful alternative asset firms, announced that its managed funds have entered into definitive agreements to acquire Emerald Holding, Inc., the owner of MJBizCon and MJBizDaily, in an all-cash transaction valued at roughly $1.5 billion. The deal will take Emerald off the New York ...
Ascend Wellness Shuts Down Lansing Cultivation Facility
LANSING – In a move that reflects ongoing adjustments in Michigan’s Cannabis sector, Ascend Wellness Holdings is shutting down operations at its Lansing cultivation site. The decision comes after a fire late last year and amid broader market pressures that have challenged many operators. Operations set to end by June 26. The company notified state ...
Cannabis and Alcohol Push Back Against Proposed Hemp Regulation Bill
WASHINGTON – Competing industry interests are shaping the debate over federal hemp policy as lawmakers weigh alternatives to an impending ban on many hemp-derived products. A new legislative effort highlights the tensions between established markets and emerging ones. Rep. Andy Barr (R) is preparing to introduce the Lawful Hemp Protection Act (LHPA). The measure seeks ...
Research and Markets Report Sets a $28B Target on Cannabis Tech
DUBLIN – The Cannabis industry has transformed from plant cultivation to infrastructure development. Today, institutional-grade technologies reshape the way the global supply chain works, and the numbers behind this evolution are capturing the attention of sectors far beyond Cannabis. A new report from Research and Markets places the global Cannabis technology sector on track to ...
Europe Medical Cannabis to Reach $13 Billion by 2034, IMARC Group Reports
NEW YORK – A fresh industry report highlights substantial potential in Europe's regulated medical Cannabis market as more countries refine access rules and patient numbers climb. The analysis from IMARC Group points to steady expansion driven by policy shifts and clinical demand, offering a snapshot of where the sector stands today. Germany remains the clear ...
Bioxyne Double-Strikes in LATAM and Europe
SYDNEY – Bioxyne Limited, an international health and life sciences company focused on the manufacturing and distribution of novel medicines, including medical Cannabis, psilocybin, and MDMA, has signed two new commercial agreements – one stretching into Latin America, the other deepening a European foothold. Bioxyne's wholly-owned subsidiary Breathe Life Sciences (BLS) has executed an expanded ...
Rubicon Organics Reports Q1 2026 Financial Results
VANCOUVER – Rubicon Organics Inc. delivered its first-quarter report, revealing results that show both progress and short-term pressures common in an industry shifting toward larger-scale operations – all while balancing strong market share gains with the short-term financial drag of expansion. The company, specializing in organic premium Cannabis products, posted net revenue of $13.7 million ...
BREAKING: Colorado Passes Landmark Ibogaine Research Bill, Expanding the State’s Natural Medicine Framework
DENVER- Colorado has taken another major step in the evolution of regulated psychedelic medicine. The Colorado legislature has passed House Bill 26-1325, a landmark measure that establishes an ibogaine research pilot program within the state’s Behavioral Health Administration. The bill authorizes up to five research sites to study the safety and effectiveness of ibogaine for ...
The DEA Window: The Real Fight Is Over Who Qualifies as Medical Cannabis
WASHINGTON, D.C. - The real significance of the DEA window is not that the Cannabis industry needs another explanation of legalization. Operators, investors, attorneys, and regulators already understand the limits of federal reform. The more important issue is whether state medical Cannabis licenses, medical designations, and documented medical operations will be enough to qualify under ...
Study: Older Americans Are Turning to Cannabis as an Alternative to Pharmaceuticals
NEW YORK - Older Americans are increasingly looking at Cannabis not as a lifestyle product, but as a practical alternative to traditional pharmaceuticals. A new study highlighted by NORML points to a growing trend among adults aged 60 and older: many are turning to Cannabis products because they are dissatisfied with conventional medications, concerned about ...
Definium Doses First Patient in Second Phase 3 LSD-Based Trial
NEW YORK – Definium Therapeutics Inc. has taken another step forward in its late-stage testing of a psychedelic-derived treatment for major depressive disorder. The company announced that the first participant received a dose in the Ascend study, its second Phase 3 trial of DT120 ODT. DT120 ODT is Definium’s proprietary orally disintegrating tablet formulation of ...
Glass House Brands Reports Q1 2026 Financial Results
LONG BEACH – Glass House Brands Inc. released its first-quarter earnings for 2026, showing revenue slightly ahead of internal expectations but down from the year-ago period, with profitability pressured by higher costs and soft wholesale pricing in California. The vertically-integrated Cannabis company, known for its large-scale greenhouse operations, reported net revenue of $40.5 million, surpassing ...
Planet 13 Reports Q1 2026 Financial Results
LAS VEGAS – Planet 13 Holdings Inc. released its first-quarter 2026 financials, reflecting the effects of substantial operational changes and declines in top-line figures, yet showcasing margin gains and cost controls as indications of progress following a period of restructuring. For the three months ended March 31, revenue totaled $21.1 million, representing a 24.8% decrease ...
MariMed Reports Q1 2026 Financial Results
NORWOOD – MariMed Inc. turned in another quarter of measured progress in a tough Cannabis market. The company, with operations spanning cultivation, production, and retail facilities across multiple states, has reported year-over-year revenue growth and narrower losses, driven by gains in both retail and wholesale channels. Revenue climbed to $39.5 million in Q1 2026, up ...
